ArticleScientific reports2025
Investigating probe-receptor interactions and enhancing fluorescence guided surgery with fluorescence lifetime imaging and NF-800 in HER-2 positive esophageal adenocarcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
FLIM (Fluorescence Lifetime Imaging Microscopy) is a powerful technique used to study protein-protein interactions, enzyme kinetics dynamics, and cellular metabolism. It is also used in studying diseases like cancer, where changes in fluorescence lifetimes can indicate alterations in cellular physiology of malignancies. Recently, FLIM technology in fluorescence guidance has been applied in receptor-targeted clinical applications. Here, we propose the application of FLIM in two animal models of esophageal adenocarcinoma, xenograft and orthotopic with a HER-2 targeting probe (Nanofitin-IRDye800CW, NF-800 hereafter) previously developed. Moreover, the technique was used to further investigate the determinants of lifetime during probe-receptor interactions. The presented data indicates that FLIM is a powerful technique and, when coupled with NF-800, it could enhance tumor contrast, leading to new clinical applications in fluorescence guided surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.